Biotech · Private company
Valneva Austria GmbH
Track this companyFree. Adds Valneva Austria GmbH to your Dealase workspace and tells you when its record changes.
Clinical trials131 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- Biological Vaccine VLA1553Phase 3 · Chikungunya Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Blood drawPhase 3 · Japanese EncephalitisClinicalTrials.gov · fetched Nov 12, 2026
- IC51Phase 3 · EncephalitisClinicalTrials.gov · fetched Nov 12, 2026
- IC51 has given in the parent study IC51-322Phase 3 · Japanese EncephalitisClinicalTrials.gov · fetched Nov 12, 2026
- VLA1553Phase 3 · Chikungunya Virus InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Challenge StrainPhase 2 · Enterotoxigenic Escherichia Coli InfectionClinicalTrials.gov · fetched Nov 12, 2026
- VLA1701Phase 2 · Enterotoxigenic Escherichia Coli InfectionClinicalTrials.gov · fetched Nov 12, 2026
- 3M-052-AFPhase 1 · ZikaClinicalTrials.gov · fetched Nov 12, 2026
- CpG 1018®Phase 1 · ZikaClinicalTrials.gov · fetched Nov 12, 2026
- VLA1553Phase 1 · ChikungunyaClinicalTrials.gov · fetched Nov 12, 2026
- VLA1601Phase 1 · ZikaClinicalTrials.gov · fetched Nov 12, 2026
- VLA1601Phase 1 · Zika VirusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- Phase 1 Trial to Assess the Safety and Immunogenicity of an Inactivated, Adjuvanted Whole Zika Virus Vaccine Candidate (VLA1601) in Healthy AdultsPHASE1 · COMPLETED · started Mar 25, 2024ClinicalTrials.gov NCT06334393 · fetched Nov 12, 2026
- An Efficacy, Safety, Tolerability, Immunogenicity, and Lot-Consistency Clinical Trial of a 6-Valent OspA-Based Lyme Disease Vaccine (VLA15)PHASE3 · COMPLETED · started Aug 4, 2022ClinicalTrials.gov NCT05477524 · fetched Nov 12, 2026
- Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553)PHASE3 · ACTIVE_NOT_RECRUITING · started Apr 2, 2021ClinicalTrials.gov NCT04838444 · fetched Nov 12, 2026
- Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study PopulationPHASE2 · COMPLETED · started Mar 8, 2021ClinicalTrials.gov NCT04801420 · fetched Nov 12, 2026
- Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy AdultsPHASE3 · COMPLETED · started Feb 22, 2021ClinicalTrials.gov NCT04786444 · fetched Nov 12, 2026
- Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in AdultsPHASE3 · COMPLETED · started Sep 17, 2020ClinicalTrials.gov NCT04546724 · fetched Nov 12, 2026
- Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme BorreliosisPHASE2 · COMPLETED · started Jul 1, 2019ClinicalTrials.gov NCT03970733 · fetched Nov 12, 2026
- Study Confirming A Human Challenge Model and Investigating The Safety Of VLA1701PHASE2 · COMPLETED · started Jun 4, 2018ClinicalTrials.gov NCT03576183 · fetched Nov 12, 2026
- Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy VolunteersPHASE1 · COMPLETED · started Mar 5, 2018ClinicalTrials.gov NCT03382964 · fetched Nov 12, 2026
- Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy AdultsPHASE1 · COMPLETED · started Feb 24, 2018ClinicalTrials.gov NCT03425149 · fetched Nov 12, 2026
- Study Assessing the Safety, Immunogenicity and Dose Response of VLA15, A New Vaccine Candidate Against Lyme BorreliosisPHASE1 · COMPLETED · started Jan 31, 2017ClinicalTrials.gov NCT03010228 · fetched Nov 12, 2026
- Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-StudyPHASE3 · COMPLETED · started Oct 1, 2010ClinicalTrials.gov NCT01246479 · fetched Nov 12, 2026
- Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic CountriesPHASE3 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01047839 · fetched Nov 12, 2026